NASDAQ NMS - GLOBAL MARKET · MIRM
+1.40% · +$1.46 · Vol 576.7K
After hours · updated 16:00:01 ET
Mirum Pharmaceuticals Inc

Mirum Pharmaceuticals Inc

Biotechnology
$105.79
Card
Relationship Map

Veridion Score

BETALOW CONF · 6/6 factorsMethodology
MIRM
Mirum Pharmaceuticals Inc
Wed Aug 5 · session closed · Markets closed · resumes Thu 9:30 ET
NEUTRAL

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

46/ 100
Veridion Score
NEUTRAL · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 6/6 factors with data · Wed Aug 5 · session closed · Markets closed · resumes Thu 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is MIRM moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading MIRM catalysts
About Mirum Pharmaceuticals Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2019
Employees
418
Country
US

Mirum Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare and orphan diseases. Its main product, Livmarli (maralixibat), is an orally administered IBAT inhibitor approved to treat cholestatic pruritus in patients with Alagille syndrome. The company is also developing treatments such as maralixibat for PFIC and ALGS, and volixibat for adult cholestatic liver diseases. Mirum currently has three approved medicines: Livmarli, Cholbam, and Ctexli.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$105.93
Day high
$107.00
Day low
$104.16
Previous close
$104.33
52W high
$128.57
-17.72% from high
52W low
$51.84
70% of range
Market cap
$6.4B
EPS
$-13.8000
Beta
0.78
Shares out
61M
Volume
576.7K
0.71× rel vol
Avg volume
812.7K
VWAP
$105.26
Price history computed in-house
1W
-1.65%
1M
-13.22%
3M
+2.78%
1Y
+104.07%
YTD
+33.93%
SMA 50 $109.59 · below
SMA 200 $92.80 · above
52W position 70%

MIRM overview

Veridion Score
46
6 of 6 factors measured
Congress receipts
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around MIRM.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading MIRM Form 4 filings
Public disclosures

Congress activity in MIRM

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for MIRM in the cached public ledger.

Federal contracts

MIRM contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for MIRM in this window.
Lobbying spend

MIRM lobbying filings, year to date.

Registered lobbying filings matched to Mirum Pharmaceuticals Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for MIRM in this window.
Loading news for MIRM
Analyst ratings
Sovereign unlock shows live analyst consensus for MIRM.
Options
Sovereign unlock shows live options positioning for MIRM.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.